Author
-
Recent Posts
Categories
Share this page:
Tag Archives: ALT
How Does Deferasirox Reduce Liver Fibrosis?
Liver fibrosis is reduced in patients with iron overload β-thalassemia and hepatitis C given the iron chelator deferasirox, according to Yves Deugnier et al. in the October issue of Gastroenterology. The liver is the main site of iron accumulation in … Continue reading
Posted in Practice
Tagged ALT, Cirrhosis, Clinical Trial, HCV, hepatitis, iron, Ishak stage, liver diseaes, outcome, therapy
Leave a comment


